Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study
This study demonstrated the association of HCTZ treatment with a better prognosis of CRC patients.
Authors
- CC Foo (ORCID: https://orcid.org/0000-0001-8849-6597)
- Ryan Wai‐Yan Sin (ORCID: https://orcid.org/0000-0003-2082-822X)
- A Man
- Zheng Huang (ORCID: https://orcid.org/0000-0002-0190-6037)
- Lui Ng (ORCID: https://orcid.org/0000-0002-9010-2654)
- Jiaxi Li (ORCID: https://orcid.org/0009-0002-7211-4683)
- Shi Sui
- Wai‐Lun Law
Institutions
- Chinese University of Hong Kong (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3389/fphar.2025.1449062
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00